- Home
- LVTX vs SDST Comparison
LVTX vs SDST Comparison
Compare LVTX & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- SDST
- Stock Information
- Founded
- LVTX 2016
- SDST 2022
- Country
- LVTX Netherlands
- SDST United States
- Employees
- LVTX N/A
- SDST N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- LVTX Health Care
- SDST Finance
- Exchange
- LVTX Nasdaq
- SDST Nasdaq
- Market Cap
- LVTX 30.0M
- SDST 33.1M
- IPO Year
- LVTX 2021
- SDST N/A
- Fundamental
- Price
- LVTX $1.25
- SDST $0.50
- Analyst Decision
- LVTX Hold
- SDST Strong Buy
- Analyst Count
- LVTX 3
- SDST 2
- Target Price
- LVTX $3.17
- SDST $1.73
- AVG Volume (30 Days)
- LVTX 48.1K
- SDST 523.1K
- Earning Date
- LVTX 05-20-2025
- SDST 05-14-2025
- Dividend Yield
- LVTX N/A
- SDST N/A
- EPS Growth
- LVTX N/A
- SDST N/A
- EPS
- LVTX N/A
- SDST N/A
- Revenue
- LVTX $11,982,000.00
- SDST N/A
- Revenue This Year
- LVTX N/A
- SDST $4,114.37
- Revenue Next Year
- LVTX N/A
- SDST N/A
- P/E Ratio
- LVTX N/A
- SDST N/A
- Revenue Growth
- LVTX 77.01
- SDST N/A
- 52 Week Low
- LVTX $0.85
- SDST $0.41
- 52 Week High
- LVTX $3.20
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- LVTX 49.77
- SDST N/A
- Support Level
- LVTX $1.17
- SDST N/A
- Resistance Level
- LVTX $1.37
- SDST N/A
- Average True Range (ATR)
- LVTX 0.08
- SDST 0.00
- MACD
- LVTX -0.01
- SDST 0.00
- Stochastic Oscillator
- LVTX 29.85
- SDST 0.00
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).